The Oncology Association of Bosnia and Herzegovina's Recommendations for Fertility Preservation in Oncologic Patients

Abstract

Malignancy is one of the major public health problems in Bosnia and Herzegovina. Along with breakthroughs in specific oncological therapy, improving the quality of life of cancer patients and management of therapy-induced side effects need to be recognized as a priority in the comprehensive cancer patient care. Fertility loss after cancer treatment is a field requiring special attention due to its various consequences on patients themselves. Although oncofertility is well-recognized area of oncology, low- to middle-income countries are facing issues with its implementation in everyday practice. Increased awareness about fertility preservation is of high priority for all specialists who participate in the medical care of cancer patients. The absence of a systemic solution and lack of expertise led to the founding of Fertility Preservation Working Group of the Oncology Association of Bosnia and Herzegovina. We have made recommendationsas an expert consensus with the ultimate goal of making the first step towards enhancement of oncofertility implementation in Bosnia and Herzegovina.

Oncofertility in pediatric patients: current perspectives

“…In the following year, the ASCO updated their guidelines on fertility preservation in cancer patients [91]. More recently, in 2021 a Spanish multidisciplinary consensus about this topic was published, and in 2022 similar recommendations were issued by the Oncology Association of Bosnia and Herzegovina [92]. Overall, all recommendations have similar points of view.…”